Etanercept-Induced Pneumonitis: Severe Complication of Tumor Necrosis Factor-Alpha Blocker Treatment

Isr Med Assoc J. 2015 Feb;17(2):130-2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Disease Progression
  • Etanercept
  • Female
  • Glucocorticoids / administration & dosage*
  • Humans
  • Image-Guided Biopsy
  • Immunoglobulin G* / administration & dosage
  • Immunoglobulin G* / adverse effects
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Intubation, Intratracheal
  • Lung / diagnostic imaging
  • Lung / pathology
  • Lung Diseases, Interstitial* / chemically induced
  • Lung Diseases, Interstitial* / diagnosis
  • Lung Diseases, Interstitial* / physiopathology
  • Lung Diseases, Interstitial* / therapy
  • Middle Aged
  • Radiography
  • Receptors, Tumor Necrosis Factor* / administration & dosage
  • Recombinant Fusion Proteins / administration & dosage
  • Recombinant Fusion Proteins / adverse effects
  • Thoracic Surgery, Video-Assisted / methods
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Anti-Bacterial Agents
  • Glucocorticoids
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • Etanercept